| Entry |
|
|---|
| Name |
Nandrolone;
17beta-Hydroxyestr-4-en-3-one;
17beta-Hydroxy-4-estren-3-one
|
|---|
| Formula |
C18H26O2
|
|---|
| Exact mass |
274.1933
|
|---|
| Mol weight |
274.40
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Brite |
Lipids [BR:br08002]
ST Sterol lipids
ST02 Steroids
ST0201 C18 steroids (estrogens) and derivatives
C07254 Nandrolone
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A14 ANABOLIC AGENTS FOR SYSTEMIC USE
A14A ANABOLIC STEROIDS
A14AB Estren derivatives
A14AB01 Nandrolone
D08250 Nandrolone (INN)
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01X OTHER OPHTHALMOLOGICALS
S01XA Other ophthalmologicals
S01XA11 Nandrolone
D08250 Nandrolone (INN)
Drug groups [BR:br08330]
Hormonal agent
DG01590 Androgen receptor agonist
DG01605 Anabolic steroid
DG00142 Nandrolone
D08250 Nandrolone
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
3-Ketosteroid receptor
NR3C4 (AR)
D08250 Nandrolone (INN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 20
1 C1y C 27.4712 -17.4882
2 C1y C 26.2333 -18.1539
3 C1z C 27.4187 -16.1394
4 C1x C 29.7196 -17.5175
5 C1y C 25.0712 -17.4708
6 C1x C 26.2333 -19.5029
7 C1x C 26.2509 -15.4620
8 C1y C 28.5807 -15.4853
9 C1a C 27.3719 -14.7963
10 C1x C 29.7370 -16.1685
11 C1y C 23.8975 -18.1422
12 C1x C 25.0829 -16.1277
13 C1x C 25.0595 -20.1744
14 O1a O 28.6742 -13.8501
15 C2y C 23.8917 -19.4912
16 C1x C 22.7296 -17.4648
17 C2x C 22.7296 -20.1686
18 C1x C 21.5559 -18.1422
19 C5x C 21.5559 -19.4912
20 O5x O 20.3996 -20.1686
BOND 23
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 3 8 1
8 3 9 1 #Up
9 4 10 1
10 5 11 1
11 5 12 1
12 6 13 1
13 8 14 1 #Up
14 11 15 1
15 11 16 1
16 15 17 2
17 16 18 1
18 17 19 1
19 19 20 2
20 7 12 1
21 8 10 1
22 13 15 1
23 18 19 1
|
|---|
